Influence of TNF- α inhibition on oxidative stress of rheumatoid arthritis patients

Reumatismo

Volumn 67, Issue 3, 2015, Pages 97-102

  Cacciapaglia, Fabio ^a   Anelli, M G ^b   Rizzo, D ^c   Morelli, E ^c   Scioscia, C ^b   Mazzotta, D ^a   Iannone, F ^b   Lapadula, G ^b  

^a N Melli Hospital   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Morelli and Di Pierro Lab   (Italy)

Author keywords

Anti TNF; Oxidative stress; Reactive oxygen species; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CORTICOSTEROID; ETANERCEPT; GOLIMUMAB; HYDROPEROXIDE; LEFLUNOMIDE; METHOTREXATE; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; HYDROGEN PEROXIDE; OXIDIZING AGENT; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY SCORE; DISEASE CONTROL; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GENERAL HEALTH STATUS ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HUMAN; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT MONITORING; PHYSICAL DISABILITY; RHEUMATOID ARTHRITIS; AGED; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; BLOOD; DRUG EFFECTS; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84957615749     PISSN: 00487449     EISSN: 22402683     Source Type: Journal    
DOI: 10.4081/reumatismo.2015.829     Document Type: Article

References (23)

1. Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007; 120: 936-9.
2. Perricone C, Ceccarelli F, Valesini G. An overview on the geneticof rheumatoid arthritis: a never-ending story. Autoimmun Rev. 2011; 10: 599-608.
3. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39: 44-84.
4. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 4 44: 860-7.
5. García-González A, Gaxiola-Robles R, Zenteno- Savín T. Oxidative stress in patients with rheumatoid arthritis. Rev Invest Clin. 2015; 67: 46-53.
6. Datta S, Kundu S, Ghosh P, De S, Ghosh A, Chatterjee M. Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis. Clin Rheumatol. 2014; 33: 1557-64.
7. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62: 2569-81.
8. Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B, Cutolo M, et al. Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy. Clin Exp Rheumatol. 2011; 29: S7-14.
9. Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A. Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr. 2001; 131: 3208-11.
10. Pasquini A, Luchetti E, Marchetti V, Cardini G, Iorio EL. Analytical performances of d-ROMs test and BAP test in canine plasma. Definition of the normal range in healthy Labrador dogs. Vet Res Commun. 2008; 32: 137-43.
11. Söderlin MK, Andersson M, Bergman S; BARFOT study group. Second-hand exposure to tobacco smoke and its effect on disease activity in Swedish rheumatoid arthritis patients. Data from BARFOT, a multicenter study of RA. Clin Exp Rheumatol. 2013; 31: 122-4.
12. Costenbader KH, Gay S, Alarcón-Riquelme ME, Iaccarino L, Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev. 2012; 11: 604-9.
13. Kaminska B. MAPK signaling pathways as molecular targets for anti-inflammatory therapy from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005; 1754: 253-2.
14. Hansson GK, Libby P, Schönbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 2002; 91: 281-91.
15. Bizzi E, Massafra U, Laganà B, Bruzzese V, Diamanti AP, Cassol M, et al. Radiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review. Clin Rheumatol. 2014; 33: 877-84.
16. Ungvari Z, Gupte SA, Recchia FA, Batkai S, Pacher P. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol. 2005; 3: 221-9.
17. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol. 2000; 164: 6509- 19.
18. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2004; 24: 2137-42.
19. Cacciapaglia F, Navarini L, Menna P, Salvatorelli E, Minotti G, Afeltra A. Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues. Autoimmun Rev. 2011; 10: 631-5.
20. Biniecka M, Kennedy A, Ng CT, Chang TC, Balogh E, Fox E, et al. Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res Ther. 2011; 13: R121.
21. Kageyama Y, Takahashi M, Ichikawa T, Torikai E, Nagano A. Reduction of oxidative stress marker levels by anti-TNF-llantibody, infliximab, in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2008; 26: 73-80.
22. Jacobson GA, Ives SJ, Narkowicz C, Jones G. Plasma glutathione peroxidase (GSH-Px) concentration is elevated in rheumatoid arthritis: a case-control study. Clin Rheumatol. 2012; 31: 1543-7.
23. Cohen JD, Dougados M, Goupille P, Cantagrel A, Meyer O, Sibilia J, et al. Health assessment questionnaire score is the best predictor of 5 year quality of life in early rheumatoid arthritis. J Rheumatol. 2006; 33: 1936-41.